Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05229263
Other study ID # RESPECT
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 25, 2022
Est. completion date December 2024

Study information

Verified date December 2023
Source Mario Negri Institute for Pharmacological Research
Contact Anna Caroli
Phone 003903545351
Email anna.caroli@marionegri.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic kidney disease (CKD) is a global health concern because more than 10% of the world's population have it, its prevalence is increasing, and CKD is an important contributor to morbidity and mortality for this population. The majority of the people with CKD aren't aware and there are not available tools for early CKD detection and for an accurate prediction on these patients. Many CKD patients exhibit progressive renal dysfunction, demonstrating a failure of current, non-specific therapeutic strategies. Better methods are urgently needed for i) early diagnosis of CKD, and prediction of its progression for improved stratification of patients and better targeting of current treatments; and ii) to directly assess structural and functional responses of the kidney to new therapies and identify those patients who respond. Over the past decade, renal Magnetic Resonance Imaging (MRI) has emerged as a promising technique for improved understanding and characterisation of renal pathophysiology. Compared to histopathology, MRI is non-invasive and avoids sampling bias by characterising the entire kidney with high spatial resolution. In spite of a number of single centre studies showing renal MRI feasibility and potential to address a number of key clinical questions, current methodological differences across studies hinder reliable comparisons of the results, which can only be regarded as preliminary. Standardization of acquisition and processing protocols across centres is therefore needed, and this will also lead to the possibility to provide preliminary data of the multiparametric renal MRI clinical validity and utility. The purpose of this study is to standardize, assess the feasibility and provide preliminary evidence of clinical validity and utility of the multiparametric renal MRI. To reach this goal two groups of subjects are involved: - Group 1 (healthy volunteers). In this group the repeatibility and reproducibility of multiparametric renal MRI will be assessed. - Group 2 (CKD patients). In this group the feasibility, the acceptability, the reproducibility and the preliminary clinical validity of multiparametric renal MRI will be assessed.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: GROUP 1: 1. Provision of written informed consent prior to any study specific procedures 2. Male and female subjects aged more than18 years 3. Normotensive (office Systolic Blood Pressure values < 140 mmHg and Diastolic Blood Pressure values = 90 mmHg) 4. Normal renal condition for age (established by estimating Glomerular Filtration Rate using CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration, Creatinine Equation) 5. Negative result upon urine dipstick testing for haematuria or proteinuria. 6. Normal Urine Albumin-to-Creatinine Ratio (UACR) (<30 mg/g) GROUP 2: 1. Provision of written informed consent prior to any study specific procedures 2. Male and female patients aged more than18 years 3. CKD stage 2 or 3, with albuminuria up to 2000 mg Exclusion Criteria: GROUP 1 and 2 1. Previous enrollment in the present study 2. Contraindications to MRI including due to: - Claustrophobia - Pregnancy - Cardiac pacemakers or other MRI-incompatible prostheses Only GROUP 2: 1. Urine Albumin-to-Creatinine Ratio higher than 2000 mg/g or 24h urine total albumin >2 g 2. Polycystic kidney disease, renovascular disease, active/current nephrotic syndrome, reflux nephropathy and known congenital renal diseases or solitary kidney. 3. Active malignancy or acute or chronic inflammatory disease, HIV 4. Acute kidney injury, as defined by the the KDIGO guidelines, during the last three months. 5. Need of a new immunosuppressive therapy for treating renal disease relapse in the preceding three months. 6. Dialysis or kidney transplantation 7. CKD stages 4 or 5 8. New medication in the preceding two weeks (diuretic, hypertensive, SGLT2 treatment)

Study Design


Intervention

Diagnostic Test:
Non- contrast Enhanced Multiparametric Renal Magnetic Resonance
MRI is performed in a single multiparametric scan session with no need for contrast agents, and to depict changes in tissue microstructure associated with inflammation and fibrosis plus alterations in oxygenation.

Locations

Country Name City State
Denmark Aarhus University Hospital, Department of Renal Medicine Århus N
Germany University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University Heidelberg Mannheim
Italy Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò" Ranica BG
Spain Clínica Universidad de Navarra Pamplona Navarra

Sponsors (4)

Lead Sponsor Collaborator
Mario Negri Institute for Pharmacological Research Aarhus University Hospital, Clinica Universidad de Navarra, Universidad de Navarra, Heidelberg University

Countries where clinical trial is conducted

Denmark,  Germany,  Italy,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary GROUP 1: within subject total kidney volume coefficient of variation in few hour time Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time to assess total kidney volume repeatability in the whole group of healthy volunteers At day 0
Primary GROUP 1: within subject total kidney volume coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess total kidney volume reproducibility in the whole group of healthy volunteers At day 7-14
Primary GROUP 1: within subject renal artery blood flow coefficient of variation in few hour time Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time to assess renal artery blood flow repeatability in the whole group of healthy volunteers At day 0
Primary GROUP 1: within subject renal artery blood flow coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess renal artery blood flow reproducibility in the whole group of healthy volunteers At day 7-14
Primary GROUP 1: within subject cortical perfusion coefficient of variation in few hour time Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time to assess cortical perfusion repeatability in the whole group of healthy volunteers At day 0
Primary GROUP 1: within subject cortical perfusion coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical perfusion reproducibility in the whole group of healthy volunteers At day 7-14
Primary GROUP 1: within subject cortical and medullary T1 coefficient of variation in few hour time Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time to assess cortical and medullary T1 repeatability in the whole group of healthy volunteers At day 0
Primary GROUP 1: within subject cortical and medullary T1 coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical and medullary T1 reproducibility in the whole group of healthy volunteers At day 7-14
Primary GROUP 1: within subject cortical and medullary T2 coefficient of variation in few hour time Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time to assess cortical and medullary T2 repeatability in the whole group of healthy volunteers At day 0
Primary GROUP 1: within subject cortical and medullary T2 coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical and medullary T2 reproducibility in the whole group of healthy volunteers At day 7-14
Primary GROUP 1: within subject cortical and medullary R2* coefficient of variation in few hour time Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time to assess cortical and medullary R2* repeatability in the whole group of healthy volunteers At day 0
Primary GROUP 1: within subject cortical and medullary R2* coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical and medullary R2* reproducibility in the whole group of healthy volunteers At day 7-14
Primary GROUP 1: within subject cortical and medullary ADC coefficient of variation in few hour time Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time to assess cortical and medullary ADC repeatability in the whole group of healthy volunteers At day 0
Primary GROUP 1: within subject cortical and medullary ADC coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical and medullary ADC reproducibility in the whole group of healthy volunteers At day 7-14
Primary GROUP 2 - Percentage of complete renal MRI data collection and analysis Percentage of complete renal MRI data acquired and generated by MRI data processing in the whole group of CKD patients, to assess feasibility of multiparametric renal MRI in CKD patients At day 0
Secondary GROUP 1 - within subject renal total kidney volume coefficient of variation in few hour time by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in male and female healthy volunteers to assess differences in total kidney volume repeatability between genders At day 0
Secondary GROUP 1 - within subject renal artery blood flow coefficient of variation in few hour time by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in male and female healthy volunteers to assess differences in renal artery blood flow repeatability between genders At day 0
Secondary GROUP 1 - within subject cortical perfusion coefficient of variation in few hour time by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in male and female healthy volunteers to assess differences in cortical perfusion repeatability between genders At day 0
Secondary GROUP 1 - within subject cortical and medullary T1 coefficient of variation in few hour time by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in male and female healthy volunteers to assess differences in cortical and medullary T1 repeatability between genders At day 0
Secondary GROUP 1 - within subject cortical and medullary T2 coefficient of variation in few hour time by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in male and female healthy volunteers to assess differences in cortical and medullary T2 repeatability between genders At day 0
Secondary GROUP 1 - within subject cortical and medullary R2* coefficient of variation in few hour time by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in male and female healthy volunteers to assess differences in cortical and medullary R2* repeatability between genders At day 0
Secondary GROUP 1 - within subject cortical and medullary ADC coefficient of variation in few hour time by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in male and female healthy volunteers to assess differences in cortical and medullary ADC repeatability between genders At day 0
Secondary GROUP 1 - within subject total kidney volume coefficient of variation in few hour time by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in healthy volunteers of different age to assess differences in total kidney volume repeatability between age classes At day 0
Secondary GROUP 1 - within subject renal artery blood flow coefficient of variation in few hour time by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in healthy volunteers of different age to assess difference in renal artery blood flow repeatability between age classes At day 0
Secondary GROUP 1 - within subject cortical perfusion coefficient of variation in few hour time by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in healthy volunteers of different age to assess differences in cortical perfusion repeatability between age classes At day 0
Secondary GROUP 1 - within subject cortical and medullary T1 coefficient of variation in few hour time by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in healthy volunteers of different age to assess differences in cortical and medullary T1 repeatability between age classes At day 0
Secondary GROUP 1 - within subject cortical and medullary T2 coefficient of variation in few hour time by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in healthy volunteers of different age to assess differences in cortical and medullary T2 repeatability between age classes At day 0
Secondary GROUP 1 - within subject cortical and medullary R2* coefficient of variation in few hour time by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in healthy volunteers of different age to assess differences in cortical and medullary R2* repeatability between age classes At day 0
Secondary GROUP 1 - within subject cortical and medullary ADC coefficient of variation in few hour time by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated in few hour time in healthy volunteers of different age to assess differences in cortical and medullary ADC repeatability between age classes At day 0
Secondary GROUP 1 - within subject total kidney volume coefficient of variation after 1-2 weeks by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in male and female healthy volunteers to assess differences in total kidney volume reproducibility between genders At day 7-14
Secondary GROUP 1 - within subject renal artery blood flow coefficient of variation after 1-2 weeks by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in male and female healthy volunteers to assess differences in renal artery blood flow reproducibility between genders At day 7-14
Secondary GROUP 1 - within subject cortical perfusion coefficient of variation after 1-2 weeks by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in male and female healthy volunteers to assess differences in cortical perfusion reproducibility between genders At day 7-14
Secondary GROUP 1 - within subject cortical and medullary T1 coefficient of variation after 1-2 weeks by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in male and female healthy volunteers to assess difference in cortical and medullary T1 reproducibility between genders At day 7-14
Secondary GROUP 1 - within subject cortical and medullary T2 coefficient of variation after 1-2 weeks by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in male and female healthy volunteers to assess differences in cortical and medullary T2 reproducibility between genders At day 7-14
Secondary GROUP 1 - within subject cortical and medullary R2* coefficient of variation after 1-2 weeks by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in male and female healthy volunteers to assess differences in cortical and medullary R2* reproducibility between genders At day 7-14
Secondary GROUP 1 - within subject cortical and medullary ADC coefficient of variation after 1-2 weeks by gender Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in male and female healthy volunteers to assess differences in cortical and medullary ADC reproducibility between genders At day 7-14
Secondary GROUP 1 - within subject total kidney volume coefficient of variation after 1-2 weeks by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in healthy volunteers of different age to assess differences in total kidney volume reproducibility between age classes At day 7-14
Secondary GROUP 1 - within subject renal artery blood flow coefficient of variation after 1-2 weeks by age Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks in healthy volunteers of different age to assess differences in renal artery blood flow reproducibility between age classes At day 7-14
Secondary GROUP 1 - within subject cortical perfusion coefficient of variation after 1-2 weeks by age Within subject coefficient of variation of measures computed by multiparametric renal MRI after 1-2 weeks in healthy volunteers of different age to assess differences in cortical perfusion reproducibility between age classes At day 7-14
Secondary GROUP 1 - within subject cortical and medullary T1 coefficient of variation after 1-2 weeks by age Within subject coefficient of variation of measures computed by multiparametric renal MRI after 1-2 weeks in healthy volunteers of different age to assess differences in cortical and medullary T1 reproducibility between age classes At day 7-14
Secondary GROUP 1 - within subject cortical and medullary T2 coefficient of variation after 1-2 weeks by age Within subject coefficient of variation of measures computed by multiparametric renal MRI after 1-2 weeks in healthy volunteers of different age to assess differences in cortical and medullary T2 reproducibility between age classes At day 7-14
Secondary GROUP 1 - within subject cortical and medullary R2* coefficient of variation after 1-2 weeks by age Within subject coefficient of variation of measures computed by multiparametric renal MRI after 1-2 weeks in healthy volunteers of different age to assess differences in cortical and medullary R2* reproducibility between age classes At day 7-14
Secondary GROUP 1 - within subject cortical and medullary ADC coefficient of variation after 1-2 weeks by age Within subject coefficient of variation of measures computed by multiparametric renal MRI after 1-2 weeks in healthy volunteers of different age to assess differences in cortical and medullary ADC reproducibility between age classes At day 7-14
Secondary GROUP 1 - Multiparametric MRI acceptability in healthy volunteers. Multiparametric MRI acceptability, in terms of comfort level and degree of satisfaction, assessed by a specific 9-item questionnaire ([9-45] range of values, with highest values denoting highest acceptability [Chen S, et al. J Appl Clin Med Phys. 2019; 20(7):184-192]) in healthy volunteers. At day 0
Secondary GROUP 2 - Multiparametric MRI acceptability in CKD patients. Multiparametric MRI acceptability, in terms of comfort level and degree of satisfaction, assessed by a specific 9-item questionnaire ([9-45] range of values, with highest values denoting highest acceptability [Chen S, et al. J Appl Clin Med Phys. 2019; 20(7):184-192]) in CKD patients. At day 0
Secondary GROUP 2 - within subject total kidney volume coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess total kidney volume reproducibility in CKD patients At day 7-14
Secondary GROUP 2 - within subject renal artery blood flow coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess renal artery blood flow reproducibility in CKD patients At day 7-14
Secondary GROUP 2 - within subject cortical perfusion coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical perfusion reproducibility in CKD patients At day 7-14
Secondary GROUP 2 - within subject cortical and medullary T1 coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical and medullary T1 reproducibility in CKD patients At day 7-14
Secondary GROUP 2 - within subject cortical and medullary T2 coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical and medullary T2 reproducibility in CKD patients At day 7-14
Secondary GROUP 2 - within subject cortical and medullary R2* coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MR repeated after 1-2 weeks to assess cortical and medullary R2* reproducibility in CKD patients At day 7-14
Secondary GROUP 2 - within subject cortical and medullary ADC coefficient of variation after 1-2 weeks Within subject coefficient of variation of measures computed by multiparametric renal MRI repeated after 1-2 weeks to assess cortical and medullary ADC reproducibility in CKD patients At day 7-14
Secondary GROUP 2 - Correlation coefficient between MRI-based parameters and eGFR Assessment of the correlation coefficient between MRI-based parameters and eGFR to provide preliminary evidence of the nature and degree of change in multiparametric MRI measures across different stages of CKD At day 0
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1